Last updated: 5 September 2024 at 4:39pm EST

Christopher Patusky Net Worth




The estimated Net Worth of Christopher Patusky is at least $4.24 Million dollars as of 3 September 2024. Mr. Patusky owns over 5,000 units of United Therapeutics Corp stock worth over $1,800,188 and over the last 20 years he sold UTHR stock worth over $1,944,471. In addition, he makes $496,604 as Lead Independent Vice Chairman of the Board at United Therapeutics Corp.

Mr. Patusky UTHR stock SEC Form 4 insiders trading

Christopher has made over 94 trades of the United Therapeutics Corp stock since 2005, according to the Form 4 filled with the SEC. Most recently he exercised 5,000 units of UTHR stock worth $877,150 on 3 September 2024.

The largest trade he's ever made was exercising 9,000 units of United Therapeutics Corp stock on 12 January 2011 worth over $244,350. On average, Christopher trades about 2,822 units every 62 days since 2005. As of 3 September 2024 he still owns at least 5,200 units of United Therapeutics Corp stock.

You can see the complete history of Mr. Patusky stock trades at the bottom of the page.





Christopher Patusky biography

Prof. Christopher Patusky J.D. serves as Lead Independent Vice Chairman of the Board of the Company. After graduating from Harvard Law School, he clerked and practiced law from 1988 to 2000, focusing on litigation, intellectual property, and business startups. After receiving a master's degree in governmental administration from the University of Pennsylvania, Mr. Patusky served from 2002 to 2007 as the Executive Director and as a member of the faculty of the University of Pennsylvania's Fels Institute of Government. From 2007 to 2011, he served as the Director of the Office of Real Estate and as a member of the Senior Policy Team at the Maryland Department of Transportation, staying on in a part-time capacity until 2013. Since 2012, Mr. Patusky has served as the founding principal of Patusky Associates, LLC, which serves as a personal investment vehicle, and as an executive manager of Slater Run Vineyards, LLC, his family's farm-based vineyard and winery. Our Board of Directors has determined that Mr. Patusky meets the financial sophistication requirements of Nasdaq's listing standards. He has served as a United Therapeutics director since 2002.

What is the salary of Christopher Patusky?

As the Lead Independent Vice Chairman of the Board of United Therapeutics Corp, the total compensation of Christopher Patusky at United Therapeutics Corp is $496,604. There are 10 executives at United Therapeutics Corp getting paid more, with Martine Rothblatt having the highest compensation of $15,627,500.



How old is Christopher Patusky?

Christopher Patusky is 57, he's been the Lead Independent Vice Chairman of the Board of United Therapeutics Corp since 2007. There are 10 older and 7 younger executives at United Therapeutics Corp. The oldest executive at United Therapeutics Corp is Louis Sullivan, 86, who is the Independent Director.

What's Christopher Patusky's mailing address?

Christopher's mailing address filed with the SEC is C/O UNITED THERAPEUTICS CORPORATION, 1000 SPRING STREET, SILVER SPRING, MD, 20910.

Insiders trading at United Therapeutics Corp

Over the last 20 years, insiders at United Therapeutics Corp have traded over $68,910,395 worth of United Therapeutics Corp stock and bought 229,703 units worth $13,655,671 . The most active insiders traders include Martine A Rothblatt, David Zaccardelli, and Roger Jeffs. On average, United Therapeutics Corp executives and independent directors trade stock every 3 days with the average trade being worth of $2,310,818. The most recent stock trade was executed by James Edgemond on 9 September 2024, trading 8,332 units of UTHR stock currently worth $991,341.



What does United Therapeutics Corp do?

united therapeutics corporation is a biotechnology company focused on the development and commercialization of unique products to address the unmet medical needs of patients with chronic and life-threatening conditions. we currently have five approved products on the market, and a long-term mission of providing an unlimited supply of transplantable organs for those who need them! our employees can be found collaborating across the united states, europe and asia. as a group, we are relentless in our pursuit of “medicines for life” and continue to research and develop treatments for cardiovascular and pulmonary diseases, pediatric cancers, and other orphan diseases. #weareunitherians



Complete history of Mr. Patusky stock trades at United Therapeutics Corp

Insider
Trans.
Transaction
Total value
Christopher Patusky
Option $877,150
3 Sep 2024
Christopher Patusky
Option $289,242
13 Jul 2024
Christopher Patusky
Option $152,720
17 Jun 2024
Christopher Patusky
Option $99,901
14 May 2024
Christopher Patusky
Sale $376,320
23 Feb 2024
Christopher Patusky
Option $176,060
7 Nov 2023
Christopher Patusky
Option $176,060
17 Aug 2023
Christopher Patusky
Option $176,060
10 May 2023
Christopher Patusky
Option $176,060
15 Mar 2023
Christopher Patusky
Option $176,060
3 Jan 2023
Christopher Patusky
Option $132,045
16 Nov 2022
Christopher Patusky
Option $227,910
17 Aug 2022
Christopher Patusky
Option $127,800
17 May 2022
Christopher Patusky
Option $127,800
7 Apr 2022
Christopher Patusky
Option $176,060
15 Mar 2022
Christopher Patusky
Option $127,800
11 Nov 2021
Christopher Patusky
Sale $460,368
8 Nov 2021
Christopher Patusky
Option $127,800
4 Aug 2021
Christopher Patusky
Option $302,400
26 Jun 2021
Christopher Patusky
Option $159,750
6 May 2021
Christopher Patusky
Option $191,700
8 Dec 2020
Christopher Patusky
Option $273,850
5 Aug 2020
Christopher Patusky
Option $275,448
26 Jun 2020
Christopher Patusky
Option $273,850
17 Mar 2020
Christopher Patusky
Option $273,850
20 Mar 2019
Christopher Patusky
Sale $373,228
7 Mar 2019
Christopher Patusky
Option $181,195
6 Jul 2018
Christopher Patusky
Option $181,667
26 Jun 2018
Christopher Patusky
Option $207,080
16 Jan 2018
Christopher Patusky
Buy $2,422
17 Jul 2017
Christopher Patusky
Option $230,878
21 Jun 2017
Christopher Patusky
Option $144,330
9 Mar 2017
Christopher Patusky
Option $144,330
9 Mar 2017
Christopher Patusky
Option $153,750
12 Jan 2017
Christopher Patusky
Option $153,750
12 Jan 2017
Christopher Patusky
Option $153,750
10 Nov 2016
Christopher Patusky
Option $153,750
1 Sep 2016
Christopher Patusky
Option $144,330
4 Aug 2016
Christopher Patusky
Option $144,330
5 May 2016
Christopher Patusky
Option $144,330
3 Mar 2016
Christopher Patusky
Option $144,330
7 Jan 2016
Christopher Patusky
Option $205,700
5 Nov 2015
Christopher Patusky
Option $205,700
6 Aug 2015
Christopher Patusky
Option $205,700
7 May 2015
Christopher Patusky
Option $205,700
5 Mar 2015
Christopher Patusky
Option $388,275
27 Feb 2015
Christopher Patusky
Option $205,700
8 Jan 2015
Christopher Patusky
Option $205,700
4 Dec 2014
Christopher Patusky
Option $153,750
7 Nov 2014
Christopher Patusky
Option $153,750
7 Aug 2014
Christopher Patusky
Option $153,750
8 May 2014
Christopher Patusky
Option $155,850
6 Mar 2014
Christopher Patusky
Option $155,850
9 Jan 2014
Christopher Patusky
Option $171,435
14 Nov 2013
Christopher Patusky
Option $109,095
7 Nov 2013
Christopher Patusky
Option $109,095
1 Aug 2013
Christopher Patusky
Option $109,095
2 May 2013
Christopher Patusky
Option $180,060
1 Mar 2013
Christopher Patusky
Option $221,600
3 Jan 2013
Christopher Patusky
Option $55,400
3 Oct 2012
Christopher Patusky
Option $55,400
5 Sep 2012
Christopher Patusky
Option $55,400
1 Aug 2012
Christopher Patusky
Option $69,250
4 Apr 2012
Christopher Patusky
Option $69,250
7 Mar 2012
Christopher Patusky
Option $65,950
1 Feb 2012
Christopher Patusky
Option $182,925
4 Jan 2012
Christopher Patusky
Option $60,975
8 Jun 2011
Christopher Patusky
Option $60,975
11 May 2011
Christopher Patusky
Option $60,975
13 Apr 2011
Christopher Patusky
Option $60,975
9 Mar 2011
Christopher Patusky
Option $60,975
9 Feb 2011
Christopher Patusky
Option $244,350
12 Jan 2011
Christopher Patusky
Option $15,730
12 Jan 2011
Christopher Patusky
Sale $230,695
29 Nov 2010
Christopher Patusky
Sale $361,860
2 Nov 2010
Christopher Patusky
Option $87,624
7 Oct 2010
Christopher Patusky
Option $9,028
3 Sep 2010
Christopher Patusky
Option $60,160
5 Aug 2010
Christopher Patusky
Option $25,280
3 Jun 2010
Christopher Patusky
Option $25,280
6 May 2010
Christopher Patusky
Option $25,280
1 Apr 2010
Christopher Patusky
Option $25,280
4 Mar 2010
Christopher Patusky
Option $25,280
4 Feb 2010
Christopher Patusky
Option $25,280
7 Jan 2010
Christopher Patusky
Option $190,381
1 Oct 2009
Christopher Patusky
Option $230,000
3 Sep 2009
Christopher Patusky
Option $107,440
5 Aug 2008
Christopher Patusky
Option $97,120
6 May 2008
Christopher Patusky
Sale $35,000
16 Nov 2007
Christopher Patusky
Option $116,350
6 Nov 2007
Christopher Patusky
Option $69,810
6 Aug 2007
Christopher Patusky
Option $79,160
4 Aug 2006
Christopher Patusky
Option $119,088
3 Nov 2005
Christopher Patusky
Sale $107,000
6 May 2005


United Therapeutics Corp executives and stock owners

United Therapeutics Corp executives and other stock owners filed with the SEC include: